Avastin may help those in early stages of breast cancer
Jan 26, 2012
The U.S. Food and Drug Administration revoked the usage of Avastin for treatment of breast cancer last November. However, two new studies show that the drug may be beneficial for those in the early stages of the disease before they undergo surgery, according to ABC News.
Avastin, which can no longer be used for late-staged breast cancer, was given to those in the early stages of breast cancer and 6 percent of the women had their tumors stop growing or disappear compared with those who did not take it. However, many are still critical of the drug.
"There is a small benefit, but how much does a 5 to 10 percent increase in tumor disappearance really mean if it does not improve survival and leads to toxicity," Dr. Charles Shapiro, director of Breast Medical Oncology at the Ohio State University Comprehensive Cancer Center told the news source.
According to the American Cancer Society, breast cancer is the second leading cause of cancer-related death among women, following only lung cancer. However, the death rate has been decreasing since 1990 due to advancements in research and breast cancer breakthrough news. There are currently 2.5 million breast cancer survivors in the United States.